ALKS

Alkermes plc

24.13 USD
-0.02 (-0.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Alkermes plc stock is up 1.17% since 30 days ago. The next earnings date is Jul 24, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.84% of the previous 30 May’s closed higher than April. In the last 7 Unusual Options Trades, there were 3 CALLs, 4 PUTs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
20 Mar 18:18 19 Apr, 2024 28.00 CALL 700 1425
26 Mar 17:07 19 Apr, 2024 30.00 PUT 15000 15118
28 Mar 17:57 19 Apr, 2024 27.00 PUT 2919 82
01 Apr 17:54 19 Apr, 2024 31.00 PUT 135 138
05 Apr 15:32 17 May, 2024 28.00 CALL 2785 47
09 Apr 13:53 17 May, 2024 28.00 CALL 2990 3104
09 May 14:16 17 May, 2024 28.00 PUT 205 209

About Alkermes plc

Alkermes plc researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL, and VUMERITY. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate.